Sign inGet started

Freebird Partners LP

Insider CIK 1955231 · CMRA 10% owner · ERNA 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CMRA Comera Life Sciences Holdi P Buy deriv2023-12-292024-01-034,907,272— $07,362,005SEC↗
CMRA Comera Life Sciences Holdi P Buy deriv2023-12-292024-01-032,453,636$0.06 $147.2K2,453,636SEC↗
ERNA Eterna Therapeutics Inc. P Buy deriv2023-12-152023-12-181,041,992— $01,991,394SEC↗
ERNA Eterna Therapeutics Inc. P Buy deriv2023-12-152023-12-18520,996$1.92 $1.00M783,233SEC↗
ERNA Eterna Therapeutics Inc. D To issuer deriv2023-12-142023-12-18424,928— $0524,474SEC↗
ERNA Eterna Therapeutics Inc. A Award deriv2023-12-142023-12-18424,928— $0949,402SEC↗
ERNA Eterna Therapeutics Inc. D To issuer deriv2023-12-142023-12-18524,474— $0424,928SEC↗
ERNA Eterna Therapeutics Inc. A Award deriv2023-12-142023-12-18524,474— $0949,402SEC↗
ERNA Eterna Therapeutics Inc. P Buy deriv2023-07-142023-07-18262,237$2.86 $750.0K262,237SEC↗
ERNA Eterna Therapeutics Inc. P Buy deriv2023-07-142023-07-18524,474— $0949,402SEC↗